2018
DOI: 10.1021/acs.jcim.8b00217
|View full text |Cite
|
Sign up to set email alerts
|

QM/MM Studies of Dph5 – A Promiscuous Methyltransferase in the Eukaryotic Biosynthetic Pathway of Diphthamide

Abstract: Eukaryotic diphthine synthase, Dph5, is a promiscuous methyltransferase that catalyzes an extraordinary N, O-tetramethylation of 2-(3-carboxy-3-aminopropyl)-l-histidine (ACP) to yield diphthine methyl ester (DTM). These are intermediates in the biosynthesis of the post-translationally modified histidine residue diphthamide (DTA), a unique and essential residue part of the eukaryotic elongation factor 2 (eEF2). Herein, the promiscuity of Saccharomyces cerevisiae Dph5 has been studied with in silico approaches, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
5
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 28 publications
1
5
0
Order By: Relevance
“…With excess levels of Dph5 being previously shown to bind and inhibit EF2, particularly when unmodified [ 13 , 19 , 24 , 58 ], cytotoxicity is expected to further increase when EF2 levels become limiting. This is exactly what we see in the composite mutant ( dph2 Δ eft2 Δ), and we therefore speculate that Dph5 –in addition to its catalytic activity as a promiscuous tetra-methylase [ 63 ] ( Fig 1 )–can negatively interfere with EF2 function and cell growth when the stepwise generation of diphthamide on EF2 is absent ( dph1 Δ- dph4 Δ) or incomplete ( dph7 Δ) [ 13 , 19 , 24 , 58 ]. Perhaps, such a regulatory rather than catalytic role for Dph5 involves binding to EF2 in order to exclude the elongation factor from functioning in mRNA translation unless licensed for full modification with diphthamide [ 11 , 13 ].…”
Section: Discussionsupporting
confidence: 69%
“…With excess levels of Dph5 being previously shown to bind and inhibit EF2, particularly when unmodified [ 13 , 19 , 24 , 58 ], cytotoxicity is expected to further increase when EF2 levels become limiting. This is exactly what we see in the composite mutant ( dph2 Δ eft2 Δ), and we therefore speculate that Dph5 –in addition to its catalytic activity as a promiscuous tetra-methylase [ 63 ] ( Fig 1 )–can negatively interfere with EF2 function and cell growth when the stepwise generation of diphthamide on EF2 is absent ( dph1 Δ- dph4 Δ) or incomplete ( dph7 Δ) [ 13 , 19 , 24 , 58 ]. Perhaps, such a regulatory rather than catalytic role for Dph5 involves binding to EF2 in order to exclude the elongation factor from functioning in mRNA translation unless licensed for full modification with diphthamide [ 11 , 13 ].…”
Section: Discussionsupporting
confidence: 69%
“…Therefore, it is necessary to clarify the above fundamental questions of SnoK and SnoN. Herein, a series of QM/MM calculations have been performed, which has been widely and successfully applied for simulating the enzymatic reactions. …”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the C3 atom of PHN, methyl group, and sulfur atom of SAM stayed in an almost linear configuration (177.48°), which is consistent with the S N 2 reaction mechanism in other methyltransferases. 19,51 In the intermediate state (Figure 5C), the methyl group covalently bonded to the C3 atom of PHN, while SAM converted to SAH. The calculated ΔE ‡ of TS1 from the reactant state was 8.6 kcal mol −1 (Figure 5D), and the calculated ΔE of the intermediate state was −32.7 kcal mol −1 .…”
Section: Qm/mm Study Of the Methyl Transfermentioning
confidence: 99%